Vortioxetine
| Use attributes for filter ! | |
| Formula | C18H22N2S |
|---|---|
| Molar mass | 298. 45 g/mol (379. 36 as hydrobromide) g·mol−1 |
| Other names | Lu AA21004 |
| Trade name | Trintellix, Brintellix, others |
| Elimination half-life | 66 hours |
| Metabolism | Extensive Liver, primarily CYP2D6-mediated oxidation |
| Music groups | Vilazodone |
| Bupropion | |
| Escitalopram | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2952719 |
About Vortioxetine
Vortioxetine, sold under the trade names Trintellix among others, is a medication used to treat major depressive disorder. Effectiveness is viewed as similar to that of other antidepressants. In Britain, it is only recommended in people who have not improved sufficiently on two other antidepressants.